Original Article

Evaluation of Chronic Hepatitis C Patients from Different Aspects Before the Use of Direct Acting Antivirals

• Sibel YILDIZ KAYA
• Bilgül METE
• Abdurrahman KAYA
• Ilker Inanç BALKAN
• Nese SALTOGLU
• Fehmi TABAK

Research Article

Long-term Sustained Virological Response Rate in Treatment of Chronic Hepatitis C Patients

• Mustafa SÜNBÜL
• Tuba KURUOĞLU
• İsmail Hakkı DÜNDAR
• Şaban ESEN
• Cafer EROĞLU
• Hakan LEBLEBİCİOĞLU

A Comparison of Interferon α-2a Plus Ribavirin Combination Therapy with Peginterferon α-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C

• Hayati DEMİRASLAN
• Bilgehan AYGEN
• Orhan YILDIZ
• Işın SOYUER
• Selma GÖKAHMETOĞLU

IFN-a2b Induction Treatment with Ribavirin in Patients with Chronic Hepatitis C

• Yunus GÜRBÜZ
• Ediz TÜTÜNCÜ
• Ruçhan TÜRKYILMAZ

The Effectivity of Combination of Standard Interferon-a + Ribavirin and Pegylated Interferon-a + Ribavirin Therapy in Patients with Chronic Hepatitis C

• Nail ÖZGÜNES
• Fatma SARGIN
• Saadet YAZICI
• Nüket CEYLAN
• Ayse Canan ÜÇISIK
• Pinar ERGEN
• Arzu DOGRU
• Özlem AYDIN

Evaluation of 219 Patients with Chronic Hepatitis C Receiving Pegylated Interferon + Ribavirin Treatment

• Nevil AYKIN
• Figen ÇAĞLAN ÇEVİK
• Hasan NAZ
• Pınar KORKMAZ
• Tercan US

Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners

• Hasan Selçuk ÖZGER
• Ömer KARAŞAHİN
• Mehmet Armağan TOY
• Sibel İBA YILMAZ
• Kenan HIZEL

Evaluation of Sustained Virological Response in Patients with Genotype 1b Chronic Hepatitis C Infection

• Esragül AKINCI
• Bircan ÜNAL KAYAASLAN
• Aliye TANRICI BAŞBUĞ
• Selim Sırrı EREN
• Pınar ÖNGÜRÜ
• Hürrem BODUR

Skin Disease after Chronic Hepatitis C: Two Cases Report

• Yunus GÜRBÜZ
• Emin Ediz TÜTÜNCÜ
• Doğan Barış ÖZTÜRK
• Ayşe BAYLAK
• İrfan ŞENCAN

Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and PegylatedInterferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of ChronicHepatitis C Infection

• Şua SÜMER
• Onur URAL
• Nazlım AKTUĞDEMİR
• Gaye URAL
• Mehmet BALCI
• Nebahat DİKİCİ

Combination of Interferon Induction Therapy and Ribavirin in Chronic Hepatitis C Patients: Results of a Multicenter Clinical Trial

• Bilgehan AYGEN
• Orhan YILDIZ
• Rahmet ÇAYLAN
• Iftihar KÖKSAL
• Nese SALTOGLU
• Yesim TASOVA
• Hakan LEBLEBICIOGLU
• Saban ESEN

Case Report

Chronic Hepatitis C Treatment-Related Skin Rash: A Report of Two Cases

• Tuğba ARSLAN GÜLEN
• Ayfer İMRE

Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report

• Tugba SARI
• Suda Tekin KORUK
• Fatih TEMOÇIN

Sensorineural Hearing Loss Due to Pegylated Interferon Alfa/Ribavirin Therapy: A Case Report

• Tuğba SARI
• Süda TEKİN KORUK
• Alaaddin ZİREK

Chronic Hepatitis C Treatment in a Thalassemia Major Patient: A Case Report

• Kaya Hüseyin Süer
• Dilara İnan

Letter to the Editor

Paradoxes in Novel Hepatitis C Therapies: Is Combination of Sofosbuvir and Ribavirin Without Interferon Effective in Genotype 1b Chronic HCV Patients?

• Ergenekon KARAGÖZ
• Vedat TURHAN
• Asim ÜLÇAY
• Alpaslan TANOĞLU
• Hakan ERDEM

Other

CHRONIC HEPATIT C TREATMENT WITH INTERFERON ALPHA 2b-RIBAVIRIN COMBINATION THERAPY

• Ismail BALIK
• Osman MEMIKOGLU

Long-Term Follow-Up of Hepatitis C Patients with Virological and Biochemical Response to Therapy and Investigation of Factors Predicting Relapses

• Bahadir CEYLAN
• Muzaffer FINCANCI
• Cüneyt MUDERRISOGLU
• Ferda SOYSAL
• Gülhan EREN

A Case of Erythema Multiforme Related to Pegylated Interferon-a2a Plus Ribavirin Treatment for Chronic Hepatitis C Virus Infection

• Ilhan ÖZGÜNES
• Elif DOYUK KARTAL
• Nurettin ERBEN
• Saygin NAYMAN ALPAT
• Gaye USLUER

Comparison of the Effect of Standard IFN-a Treatment and Standard IFN-a plus Ribavirin Therapy in Patients with Naive Chronic Hepatitis C

• Nail ÖZGÜNES
• Fatma SARGIN
• Saadet YAZICI
• Ayse Canan ÜÇISIK
• Nüket CEYLAN
• Pinar ERGEN
• Özlem AYDIN
• Arzu DOGRU